NLS Pharmaceutics Ltd. Ordinary Shares (NLSP) is a publicly traded Healthcare sector company. As of July 31, 2026, NLSP trades at $7.62 with a market cap of $3.97M and a P/E ratio of 0.00. NLSP moved -1.05% today. Year to date, NLSP is -46.34%; over the trailing twelve months it is flat. Its 52-week range spans $7.40 to $33.70. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces NLSP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NLSP, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $7.62 |
| Market Cap | $3.97M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.70 |
| 52-Week Low | $7.40 |
| Volume | 4.76M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover NLSP: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.